High Vista Strategies LLC Gh Research PLC Transaction History

High Vista Strategies LLC

  • $249 Million
  • Q2 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
BUY
$9.2 - $13.5 $81,217 - $119,178
8,828 Added 15.55%
65,597 $637,000
Q3 2022

Nov 14, 2022
SELL
$10.15 - $16.15 $72,745 - $115,747
-7,167 Reduced 11.21%
56,769 $660,000
Q2 2022

Aug 15, 2022
BUY
$8.99 - $19.87 $99,753 - $220,477
11,096 Added 21.0%
63,936 $638,000
Q1 2022

May 16, 2022
BUY
$15.48 - $23.98 $399,848 - $619,403
25,830 Added 95.63%
52,840 $966,000
Q4 2021

Feb 14, 2022
BUY
$14.1 - $27.9 $380,841 - $753,579
27,010 New
27,010 $630,000

Others Institutions Holding GHRS

# of Institutions
34
Shares Held
23.5M
Call Options Held
63.1K
Put Options Held
1.9K
View Full List

About GH Research PLC

GHRS Quotes by TradingView
  • Ticker GHRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,020,800
  • Market Cap $433M
  • Description
  • GH Research PLC, a clinical-stage biopharmaceutical company, engages in developing various therapies for the treatment of psychiatric and neurological disorders. The company focuses on developing 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) therapies for the treatment of patients with treatment-resistant depression (TRD). Its lead program is GH0...
More about GHRS
Track This Portfolio

Track High Vista Strategies LLC Portfolio

Follow High Vista Strategies LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Vista Strategies LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Vista Strategies LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email